De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer

Journal:

Nature Communications

Published:

2025-07-30

DOI:

10.1038/s41467-025-61242-x

Affiliations:

12

Authors:

17

Go to article

Institutions	Authors	Share
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	11.250000 11.250000	0.66
Aarhus University (AU), Denmark	2.000000	0.12
Harvard University, United States of America (USA)	1.166667	0.07
Harvard Medical School (HMS), United States of America (USA)	1.083333	0.06
Aarhus University Hospital, Denmark	0.500000	0.03
Broad Institute of MIT and Harvard, United States of America (USA)	0.500000	0.03
Brigham and Women's Hospital (BWH), United States of America (USA)	0.500000	0.03

Interested in Oncology and Carcinogenesis?